The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2005
DOI: 10.1021/jm050247c
|View full text |Cite
|
Sign up to set email alerts
|

A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine6(5-HT6) Receptor Antagonists

Abstract: Forty-five structurally diverse 5-hydroxytryptamine(6) receptor (5-HT(6)R) antagonists were selected to develop a 3D pharmacophore model with the Catalyst software. The structural features for antagonism at this receptor are a positive ionizable atom interacting with Asp(3.32), a hydrogen bond acceptor group interacting with Ser(5.43) and Asn(6.55), a hydrophobic site interacting with residues in a hydrophobic pocket between transmembranes 3, 4, and 5, and an aromatic-ring hydrophobic site interacting with Phe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
88
0
3

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(96 citation statements)
references
References 31 publications
5
88
0
3
Order By: Relevance
“…A 5-HT 6 antagonist pharmacophore has been previously described in the literature [7]. In our efforts to prepare potent and highly selective antagonists targeting 5-HT 6 based on this reported pharmacophore [8,9], we performed the synthesis of the title compound 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]-3-[4-(pyridin-2-yl)piperazin-1-yl]propan-1-one and evaluated its affinity for the 5-HT 6 receptor in a standard binding assay.…”
Section: Introductionmentioning
confidence: 99%
“…A 5-HT 6 antagonist pharmacophore has been previously described in the literature [7]. In our efforts to prepare potent and highly selective antagonists targeting 5-HT 6 based on this reported pharmacophore [8,9], we performed the synthesis of the title compound 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]-3-[4-(pyridin-2-yl)piperazin-1-yl]propan-1-one and evaluated its affinity for the 5-HT 6 receptor in a standard binding assay.…”
Section: Introductionmentioning
confidence: 99%
“…We wished to determine whether introduction of piperazinyl methyl group on N 1 -phenylsulfonyl moiety at C-3 0 position would have a desired effect on the binding to 5-HT 6 R and aimed to investigate the structure-activity relationship (SAR). Researchers have developed a pharmacophore model ( Figure 3) for 5-HT 6 receptor antagonists, based on reported chemically diverse 5-HT 6 receptor antagonists [35][36][37][38][39][40][41][42]34 . In this pharmacophore model, four core features were taken into consideration which include the positive ionizable atom (PI, usually a secondary or tertiary amino group), a hydrogen bond acceptor group (HBA, usually a sulfone or sulfonamide group), a hydrophobic site (HYD) and -electron donor aromatic or heterocyclic ring (AR).…”
Section: Introductionmentioning
confidence: 99%
“…Since then a lot of reports have been published regarding variations in N,N-dimethyl amino alkyl side chain on and around the indole nucleus and their affinity 21,32,33 ( Figure 2). Numerous selective antagonists of 5-HT 6 receptors have been disclosed during the last decade [34][35][36][37][38][39][40][41][42] and a pharmacophore model for this type of receptor antagonists has been developed based on known structurally diverse 5-HT 6 receptor antagonists [43][44][45][46][47][48][49] . In general, the model entails the positive ionizable atom (usually a secondary or tertiary amino group), a hydrogen bond acceptor group (usually a sulfone or sulfonamide group), a hydrophobic site (HYD) and -electron donor aromatic or heterocyclic ring (AR).…”
Section: Introductionmentioning
confidence: 99%